Home › Funds › Two Sigma Investments › DNLI
Two Sigma Investments position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q4 2025)430.18K sh
Reported value held$7.10M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 113.67K | $5.74M | New |
| Q4 2021 | 8.58K | $382.00K | Reduce |
| Q1 2022 | 30.00K | $965.00K | Add |
| Q2 2022 | 64.32K | $1.89M | Add |
| Q3 2022 | 261.17K | $8.02M | Add |
| Q4 2022 | 74.44K | $2.07M | Reduce |
| Q1 2023 | 75.74K | $1.75M | Add |
| Q2 2023 | 34.40K | $1.02M | Reduce |
| Q4 2023 | 28.38K | $608.95K | New |
| Q1 2024 | 191.50K | $3.93M | Add |
| Q2 2024 | 94.87K | $2.20M | Reduce |
| Q3 2024 | 99.47K | $2.90M | Add |
| Q4 2024 | 179.88K | $3.67M | Add |
| Q1 2025 | 102.40K | $1.39M | Reduce |
| Q2 2025 | 19.30K | $270.01K | Reduce |
| Q3 2025 | 266.29K | $3.87M | Add |
| Q4 2025 | 430.18K | $7.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026